SC 13G Filing

Company

Emergent BioSolutions Inc.

Filed

February 17, 2015

Accession Number

0000312348-15-000017

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →